Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model.
Holzgreve A, Pötter D, Brendel M, Orth M, Weidner L, Gold L, Kirchner MA, Bartos LM, Unterrainer LM, Unterrainer M, Steiger K, von Baumgarten L, Niyazi M, Belka C, Bartenstein P, Riemenschneider MJ, Lauber K, Albert NL. Holzgreve A, et al. Among authors: steiger k. Biomedicines. 2022 Mar 22;10(4):738. doi: 10.3390/biomedicines10040738. Biomedicines. 2022. PMID: 35453488 Free PMC article.
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging.
Holzgreve A, Biczok A, Ruf VC, Liesche-Starnecker F, Steiger K, Kirchner MA, Unterrainer M, Mittlmeier L, Herms J, Schlegel J, Bartenstein P, Tonn JC, Albert NL, Suchorska B. Holzgreve A, et al. Among authors: steiger k. Front Oncol. 2021 Mar 30;11:646387. doi: 10.3389/fonc.2021.646387. eCollection 2021. Front Oncol. 2021. PMID: 33859946 Free PMC article.
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook.
Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM, Barci E, Kälin RE, Glass R, Lindner S, Kaiser L, Maas J, von Baumgarten L, Ilhan H, Belka C, Notni J, Bartenstein P, Lauber K, Albert NL. Kirchner MA, et al. Among authors: steiger k. Front Oncol. 2021 Nov 17;11:774017. doi: 10.3389/fonc.2021.774017. eCollection 2021. Front Oncol. 2021. PMID: 34869017 Free PMC article.
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors.
Zellmer J, Yen HY, Kaiser L, Gildehaus FJ, Böning G, Steiger K, Hacker M, Bartenstein P, Todica A, Haug AR, Ilhan H. Zellmer J, et al. Among authors: steiger k. Biomedicines. 2022 Dec 1;10(12):3102. doi: 10.3390/biomedicines10123102. Biomedicines. 2022. PMID: 36551858 Free PMC article.
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression.
Robu S, Richter A, Gosmann D, Seidl C, Leung D, Hayes W, Cohen D, Morin P, Donnelly DJ, Lipovšek D, Bonacorsi SJ, Smith A, Steiger K, Aulehner C, Krackhardt AM, Weber WA. Robu S, et al. Among authors: steiger k. J Nucl Med. 2021 Sep 1;62(9):1228-1234. doi: 10.2967/jnumed.120.258384. Epub 2021 Jan 30. J Nucl Med. 2021. PMID: 33517324 Free PMC article.
uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils.
Uhl B, A Mittmann L, Dominik J, Hennel R, Smiljanov B, Haring F, B Schaubächer J, Braun C, Padovan L, Pick R, Canis M, Schulz C, Mack M, Gutjahr E, Sinn P, Heil J, Steiger K, Kanse SM, Weichert W, Sperandio M, Lauber K, Krombach F, Reichel CA. Uhl B, et al. Among authors: steiger k. EMBO Mol Med. 2021 Jun 7;13(6):e13110. doi: 10.15252/emmm.202013110. Epub 2021 May 16. EMBO Mol Med. 2021. PMID: 33998175 Free PMC article.
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.
Heid I, Trajkovic-Arsic M, Lohöfer F, Kaissis G, Harder FN, Mayer M, Topping GJ, Jungmann F, Crone B, Wildgruber M, Karst U, Liotta L, Algül H, Yen HY, Steiger K, Weichert W, Siveke JT, Makowski MR, Braren RF. Heid I, et al. Among authors: steiger k. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):115-129. doi: 10.1007/s00259-022-05930-6. Epub 2022 Sep 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 36074156 Free PMC article.
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.
Spellerberg R, Benli-Hoppe T, Kitzberger C, Hageneier M, Schwenk N, Öztürk Ö, Steiger K, Multhoff G, Eiber M, Schilling F, Weber WA, Kälin RE, Glass R, Nelson PJ, Wagner E, Spitzweg C. Spellerberg R, et al. Among authors: steiger k. Mol Ther Oncolytics. 2022 Nov 3;27:272-287. doi: 10.1016/j.omto.2022.10.013. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36458201 Free PMC article.
341 results